Jonathan G Drachman's Net Worth
-$661 Thousand
Who is Jonathan G Drachman?
Jonathan G Drachman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Calithera Biosciences, Inc., Neoleukin Therapeutics, Inc., and Harpoon Therapeutics, Inc..
SEC CIK
Jonathan G Drachman's CIK is 0001588467
Past Insider Trading and Trends
2019 was Jonathan G Drachman's most active year for acquiring shares with 13 total transactions. Jonathan G Drachman's most active month to acquire stocks was the month of July. 2017 was Jonathan G Drachman's most active year for disposing of shares, totalling 12 transactions. Jonathan G Drachman's most active month to dispose stocks was the month of February. 2019 saw Jonathan G Drachman paying a total of $1,781,741.38 for 4,228,591 shares, this is the most they've acquired in one year. In 2017 Jonathan G Drachman cashed out on 91,318 shares for a total of $2,068,032.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEATTLE GENETICS INC /WA (SGEN) No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
| +18.16% | 31.04K |
$14.15 | $439,134.38 | 201.97K |
Mar 20
| |||
Form 4
|
—
|
0
|
$30.90 | -$458,757.12 | 170.93K |
Scheduled
|
Mar 5
| ||
Form 4
| +12.81% | 19.42K |
$11.06 | $214,705.16 | 170.93K |
Jan 11
| |||
Form 4
| +13.33% | 17.82K |
$11.52 | $205,252.93 | 151.52K |
Oct 5
| |||
Form 4
| -5.98% | -8.50K |
$47.89 | -$407,199.04 | 133.7K |
Scheduled
|
Aug 28
| ||
Form 4
|
—
|
0
|
$28.92 | -$372,514.00 | 142.2K |
Scheduled
|
Aug 24
| ||
Form 4
| +23.44% | 27K |
—
|
—
| 142.2K |
Aug 17
| |||
Form 4
|
—
|
0
|
$32.42 | -$442,461.00 | 115.2K |
Scheduled
|
Jul 27
| ||
Form 4
|
—
|
0
|
$37.15 | -$537,158.00 | 115.2K |
Scheduled
|
Jun 22
| ||
Form 4
| +4.55% | 5K |
$10.29 | $51,450.00 | 114.84K |
Jan 25
| |||
Form 4
|
—
|
0
|
$38.92 | -$431,420.66 | 109.84K |
Scheduled
|
Nov 9
| ||
Form 4
| -3.02% | -3.42K |
$51.74 | -$176,847.32 | 109.84K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$33.52 | -$104,488.54 | 113.25K |
Scheduled
|
Sep 22
| ||
Form 4
| +34.42% | 29K |
—
|
—
| 113.25K |
Aug 27
| |||
Form 4
| -4.52% | -3.99K |
$46.59 | -$185,943.48 | 84.25K |
Scheduled
|
Aug 22
| ||
Form 4
| +6.01% | 5K |
$10.29 | $51,450.00 | 88.25K |
Jun 2
| |||
Form 4
| +23.13% | 15.54K |
$42.02 | -$187,512.87 | 82.72K |
Scheduled
|
Aug 20 - Aug 25
| ||
Form 4
| +34.98% | 17.23K |
$43.55 | -$120,717.83 | 66.48K |
Scheduled
|
Aug 24 - Aug 26
| ||
Form 4
| -2.49% | -1.24K |
$53.25 | -$66,083.25 | 48.67K |
Scheduled
|
Feb 20
| ||
Form 4
| -2.35% | -1.20K |
$45.75 | -$54,945.75 | 49.91K |
Scheduled
|
Jan 16
| ||
Form 4
| +18.83% | 8.1K |
—
|
—
| 51.11K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 200K |
$0.86 | $171,900.00 | 200K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neoleukin Therapeutics, Inc. (NLTX) No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
| +6.67% | 150K |
$6.34 | $933,550.00 | 2.4M |
Aug 24 - Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
| +2.27% | 50K |
$9.51 | $475,354.00 | 2.25M |
Jun 3 - Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +164.69% | 1.37M |
$8.40 | $999,994.80 | 2.2M |
Nov 12 - Dec 20
| |||
Form 4/A
|
∞
| 580.65K |
—
|
—
| 580.65K |
Aug 8
| |||
Form 4
| +74.75% | 250K |
$3.13 | $781,746.58 | 584.43K |
Sep 9 - Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
∞
| 341.86K |
—
|
—
| 341.86K |
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.335
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.00K |
—
|
—
|
0
|
Mar 8 - Mar 11
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||